Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
BACKGROUND: Neuromyelitis optica (NMO) is a severe inflammatory demyelinating disease that predominantly affects the optic nerve and spinal cord. Since the discovery of a specific serum marker for NMO in 2004, and its subsequent identification as an antibody to aquaporin-4 (AQP-4), various methods...
Main Authors: | Waters, P, Vincent, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
by: Waters, P, et al.
Published: (2016) -
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
by: Jarius, S, et al.
Published: (2008) -
Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
by: Akman-Demir, G, et al.
Published: (2011) -
Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
by: Min, J, et al.
Published: (2010) -
Antibodies to aquaporin-1 are not present in neuromyelitis optica
by: Waters, P, et al.
Published: (2015)